Selvita S.A. (WAR:SLV) — Market Cap & Net Worth
Market Cap & Net Worth: Selvita S.A. (SLV)
Selvita S.A. (WAR:SLV) has a market capitalization of $176.81 Million (zł642.44 Million) as of May 2, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #16991 globally and #111 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Selvita S.A.'s stock price zł35.00 by its total outstanding shares 18355474 (18.36 Million). Analyse SLV cash flow conversion to see how efficiently the company converts income to cash.
Selvita S.A. Market Cap History: 2019 to 2026
Selvita S.A.'s market capitalization history from 2019 to 2026. Data shows growth from $118.71 Million to $176.81 Million (8.12% CAGR).
Index Memberships
Selvita S.A. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
mWIG40
MWIG40
|
$65.21 Billion | 0.27% | #36 of 40 |
Weight: Selvita S.A.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Selvita S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Selvita S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.73x
Selvita S.A.'s market cap is 0.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $118.71 Million | $30.44 Million | $5.52 Million | 3.90x | 21.49x |
| 2020 | $249.05 Million | $137.36 Million | $18.00 Million | 1.81x | 13.84x |
| 2021 | $414.24 Million | $310.92 Million | $14.90 Million | 1.33x | 27.80x |
| 2022 | $418.79 Million | $360.68 Million | $30.31 Million | 1.16x | 13.82x |
| 2023 | $295.52 Million | $346.72 Million | $69.88 Million | 0.85x | 4.23x |
| 2024 | $250.06 Million | $342.01 Million | -$6.10 Million | 0.73x | N/A |
Competitor Companies of SLV by Market Capitalization
Companies near Selvita S.A. in the global market cap rankings as of May 2, 2026.
Key companies related to Selvita S.A. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Selvita S.A. Historical Marketcap From 2019 to 2026
Between 2019 and today, Selvita S.A.'s market cap moved from $118.71 Million to $ 176.81 Million, with a yearly change of 8.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł176.81 Million | -18.98% |
| 2025 | zł218.23 Million | -12.73% |
| 2024 | zł250.06 Million | -15.38% |
| 2023 | zł295.52 Million | -29.43% |
| 2022 | zł418.79 Million | +1.10% |
| 2021 | zł414.24 Million | +66.33% |
| 2020 | zł249.05 Million | +109.79% |
| 2019 | zł118.71 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Selvita S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $176.81 Million USD |
| MoneyControl | $176.81 Million USD |
| MarketWatch | $176.81 Million USD |
| marketcap.company | $176.81 Million USD |
| Reuters | $176.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Selvita S.A.
Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational re… Read more